Biologics Market Transparency Act of 2022

United States117th CongressS-4302Senate
Updated: May 25, 2022

Summary

Biologics Market Transparency Act of 2022 This bill requires biologics manufacturers to notify the Food and Drug Administration in advance of withdrawing a product from sale.

Bill texts

Available versions
Introduced (Senate)View official text

1 version available

All available records shown.

Timeline

Latest companion bill action

HR-7035: Biologics Market Transparency Act of 2022

Referred to the Subcommittee on Health.

  1. Introduced in Senate

  2. Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2709)

    Senate

All available records shown.